North Spokane contract pharmaceutical manufacturer Jubilant HollisterStier has won about $90 million in new projects stretching over five years, the firm’s parent company announced.
The contracts involve production of sterile injectable medicines for four companies that sell to customers in the United States and Europe, according to a release from Jubilant Life Sciences, the India company that owns Jubilant HollisterStier.
Confidential agreements prevent disclosure of the companies involved or the names of the drugs to be produced in Spokane, said Shannon Jordan, a Jubilant HollisterStier spokeswoman.
Even describing the medical conditions the drugs treat can be viewed as disclosing information to the four companies’ competitors, said Jordan.
The $90 million is an estimate based on past experience with contracts of this type, she added. The actual amount over five years may be more or less, depending on the clients’ projected needs.
Jubilant HollisterStier, which has a separate division that produces allergy-treatment drugs, employs about 600 workers, including temporary employees.
The new contracts could raise that number if the client companies ramp up production, she said.